Refractory Anemia With Excess of Blasts (RAEB): Clinical Trials

1 trial for Refractory Anemia With Excess of Blasts (RAEB), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. .

Follow Refractory Anemia With Excess of Blasts (RAEB): new trials by email Literature Review of Refractory Anemia With Excess of Blasts (RAEB) trials Research Report on Refractory Anemia With Excess of Blasts (RAEB)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL)
TerminatedSkyline Diagnostics BV2642011-10-012013-05-29

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Promyelocytic, Acute (1)

Broader conditions

Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

Skyline Diagnostics BV (1)

Countries

Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Alan Burnett, MD (1)  ·  Bob Lowenberg, MD (1)  ·  Guido Marcucci, MD (1)  ·  Hartmut Doehner, MD (1)  ·  Martin Tallman, MD (1)